CN112852937A - 一种呼吸道病原微生物检测引物组合、试剂盒及其应用 - Google Patents
一种呼吸道病原微生物检测引物组合、试剂盒及其应用 Download PDFInfo
- Publication number
- CN112852937A CN112852937A CN202110260532.9A CN202110260532A CN112852937A CN 112852937 A CN112852937 A CN 112852937A CN 202110260532 A CN202110260532 A CN 202110260532A CN 112852937 A CN112852937 A CN 112852937A
- Authority
- CN
- China
- Prior art keywords
- seq
- primer
- respiratory tract
- nucleotide sequence
- adptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000000010 microbial pathogen Species 0.000 title claims abstract description 66
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 23
- 238000001514 detection method Methods 0.000 title claims abstract description 22
- 108020004414 DNA Proteins 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000012163 sequencing technique Methods 0.000 claims abstract description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 5
- 238000003745 diagnosis Methods 0.000 claims abstract description 5
- 238000012408 PCR amplification Methods 0.000 claims description 31
- 239000002773 nucleotide Substances 0.000 claims description 23
- 125000003729 nucleotide group Chemical group 0.000 claims description 23
- 230000000241 respiratory effect Effects 0.000 claims description 17
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 239000002299 complementary DNA Substances 0.000 claims description 7
- 238000012165 high-throughput sequencing Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 238000010804 cDNA synthesis Methods 0.000 claims description 5
- 230000001717 pathogenic effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000700605 Viruses Species 0.000 abstract description 8
- 244000005700 microbiome Species 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 5
- 206010057190 Respiratory tract infections Diseases 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 241000606161 Chlamydia Species 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 3
- 241000204031 Mycoplasma Species 0.000 abstract description 3
- 241000450599 DNA viruses Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 241001493065 dsRNA viruses Species 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000000203 mixture Substances 0.000 description 23
- 239000011324 bead Substances 0.000 description 18
- 238000001179 sorption measurement Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 206010036790 Productive cough Diseases 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- 230000003321 amplification Effects 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 210000003802 sputum Anatomy 0.000 description 10
- 208000024794 sputum Diseases 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000003908 quality control method Methods 0.000 description 7
- 239000002096 quantum dot Substances 0.000 description 7
- 239000002699 waste material Substances 0.000 description 6
- 241000725643 Respiratory syncytial virus Species 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 241000709661 Enterovirus Species 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000003766 bioinformatics method Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000007403 mPCR Methods 0.000 description 3
- 241001647378 Chlamydia psittaci Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 239000012487 rinsing solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- LITBAYYWXZOHAW-XDZRHBBOSA-N (2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]hept Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 LITBAYYWXZOHAW-XDZRHBBOSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000124740 Bocaparvovirus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010021450 Immunodeficiency congenital Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 241000233870 Pneumocystis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 229960003169 biapenem Drugs 0.000 description 1
- MRMBZHPJVKCOMA-YJFSRANCSA-N biapenem Chemical compound C1N2C=NC=[N+]2CC1SC([C@@H]1C)=C(C([O-])=O)N2[C@H]1[C@@H]([C@H](O)C)C2=O MRMBZHPJVKCOMA-YJFSRANCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000005015 mediastinal lymph node Anatomy 0.000 description 1
- 229960002260 meropenem Drugs 0.000 description 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 201000000317 pneumocystosis Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
文库编号 | Qubit浓度(ng/μL) | 体积(μL) |
A1-L | 19.4 | 20 |
A2-L | 21.3 | 20 |
样本 | 类型 | 中文名 | 拉丁名 | Reads | Reads占比 |
A1 | MC | 鹦鹉热衣原体 | Chlamydia psittaci | 551 | 84.3% |
A1 | F | 烟曲霉 | Aspergillus fumigatus | 103 | 15.7% |
A2 | MT | 结核分枝杆菌 | Mycobacterium tuberculosis | 49 | 4.0% |
A2 | V | 人疱疹病毒4型(EBV) | Human herpesvirus 4 | 1120 | 91.7% |
A2 | V | 人疱疹病毒4型(CMV) | Human herpesvirus 5 | 53 | 4.3% |
文库编号 | Qubit浓度(ng/μL) | 体积(μL) |
B1-L | 26.3 | 20 |
B2-L | 21.7 | 20 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110260532.9A CN112852937B (zh) | 2021-03-10 | 2021-03-10 | 一种呼吸道病原微生物检测引物组合、试剂盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110260532.9A CN112852937B (zh) | 2021-03-10 | 2021-03-10 | 一种呼吸道病原微生物检测引物组合、试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112852937A true CN112852937A (zh) | 2021-05-28 |
CN112852937B CN112852937B (zh) | 2021-11-09 |
Family
ID=75995220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110260532.9A Active CN112852937B (zh) | 2021-03-10 | 2021-03-10 | 一种呼吸道病原微生物检测引物组合、试剂盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112852937B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115976281A (zh) * | 2022-11-18 | 2023-04-18 | 中国农业大学 | 一种通过高通量靶向测序实现猪15种病原同时检测的引物组及应用 |
CN116200537A (zh) * | 2022-10-14 | 2023-06-02 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种呼吸道合胞病毒a型全基因组测序方法 |
CN116287357A (zh) * | 2023-05-16 | 2023-06-23 | 北京百奥益康医药科技有限公司 | 一种基于靶向扩增子测序的呼吸道病原菌检测试剂盒 |
CN116287479A (zh) * | 2023-05-16 | 2023-06-23 | 北京百奥益康医药科技有限公司 | 一种检测呼吸道病毒的引物组合及其应用 |
CN116875718A (zh) * | 2023-09-07 | 2023-10-13 | 南京诺因生物科技有限公司 | 结核分枝杆菌耐药突变位点测序文库的构建方法及试剂盒 |
CN117025809A (zh) * | 2023-10-09 | 2023-11-10 | 美格医学检验所(广州)有限公司 | 结核分歧杆菌复合群鉴定引物组合、试剂盒、方法和系统 |
CN117025808A (zh) * | 2023-10-09 | 2023-11-10 | 美格医学检验所(广州)有限公司 | 一种病原微生物检测引物组合、试剂盒和检测方法 |
CN117625848A (zh) * | 2023-12-04 | 2024-03-01 | 上海钧济医学检验所有限公司 | 基于高通量测序检测呼吸道病原体的组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276524A1 (en) * | 2009-11-16 | 2012-11-01 | Genomictree, Inc. | Genotyping method |
CN108517350A (zh) * | 2018-04-09 | 2018-09-11 | 中国人民解放军陆军军医大学第附属医院 | 多种病原体靶向建库试剂盒 |
CN110093455A (zh) * | 2019-04-27 | 2019-08-06 | 中国医学科学院病原生物学研究所 | 一种呼吸道病毒的检测方法 |
CN111705118A (zh) * | 2020-06-23 | 2020-09-25 | 宁夏医科大学总医院 | 一种基于靶基因高通量测序的血流感染检测试剂盒 |
-
2021
- 2021-03-10 CN CN202110260532.9A patent/CN112852937B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276524A1 (en) * | 2009-11-16 | 2012-11-01 | Genomictree, Inc. | Genotyping method |
CN108517350A (zh) * | 2018-04-09 | 2018-09-11 | 中国人民解放军陆军军医大学第附属医院 | 多种病原体靶向建库试剂盒 |
CN110093455A (zh) * | 2019-04-27 | 2019-08-06 | 中国医学科学院病原生物学研究所 | 一种呼吸道病毒的检测方法 |
CN111705118A (zh) * | 2020-06-23 | 2020-09-25 | 宁夏医科大学总医院 | 一种基于靶基因高通量测序的血流感染检测试剂盒 |
Non-Patent Citations (4)
Title |
---|
CHAO QI 等: "Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing", 《JOURNAL OF MEDICAL MICROBIOLOGY》 * |
何静 等: "二代测序技术检测呼吸道非典型病原体应用进展", 《实用医学杂志》 * |
贾雪洋 等: "下呼吸道感染病原体检测方法研究进展", 《中国人兽共患病学报》 * |
钮月英 等: "肺泡灌洗液宏基因二代测序技术对下呼吸道感染病原体检测的优势", 《中国实用内科杂志》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116200537A (zh) * | 2022-10-14 | 2023-06-02 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种呼吸道合胞病毒a型全基因组测序方法 |
CN116200537B (zh) * | 2022-10-14 | 2023-09-19 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种呼吸道合胞病毒a型全基因组测序方法 |
CN115976281B (zh) * | 2022-11-18 | 2023-07-25 | 中国农业大学 | 一种通过高通量靶向测序实现猪15种病原同时检测的引物组及应用 |
CN115976281A (zh) * | 2022-11-18 | 2023-04-18 | 中国农业大学 | 一种通过高通量靶向测序实现猪15种病原同时检测的引物组及应用 |
CN116287479A (zh) * | 2023-05-16 | 2023-06-23 | 北京百奥益康医药科技有限公司 | 一种检测呼吸道病毒的引物组合及其应用 |
CN116287479B (zh) * | 2023-05-16 | 2023-07-28 | 北京百奥益康医药科技有限公司 | 一种检测呼吸道病毒的引物组合及其应用 |
CN116287357A (zh) * | 2023-05-16 | 2023-06-23 | 北京百奥益康医药科技有限公司 | 一种基于靶向扩增子测序的呼吸道病原菌检测试剂盒 |
CN116875718A (zh) * | 2023-09-07 | 2023-10-13 | 南京诺因生物科技有限公司 | 结核分枝杆菌耐药突变位点测序文库的构建方法及试剂盒 |
CN116875718B (zh) * | 2023-09-07 | 2023-12-01 | 南京诺因生物科技有限公司 | 结核分枝杆菌耐药突变位点测序文库的构建方法及试剂盒 |
CN117025809A (zh) * | 2023-10-09 | 2023-11-10 | 美格医学检验所(广州)有限公司 | 结核分歧杆菌复合群鉴定引物组合、试剂盒、方法和系统 |
CN117025808A (zh) * | 2023-10-09 | 2023-11-10 | 美格医学检验所(广州)有限公司 | 一种病原微生物检测引物组合、试剂盒和检测方法 |
CN117025809B (zh) * | 2023-10-09 | 2024-03-19 | 广州精微医学科技有限公司 | 结核分歧杆菌复合群鉴定及耐药位点检测引物组合、试剂盒、方法和系统 |
CN117625848A (zh) * | 2023-12-04 | 2024-03-01 | 上海钧济医学检验所有限公司 | 基于高通量测序检测呼吸道病原体的组合物 |
CN117625848B (zh) * | 2023-12-04 | 2024-06-25 | 上海钧济医学检验所有限公司 | 基于高通量测序检测呼吸道病原体的组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN112852937B (zh) | 2021-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112852937B (zh) | 一种呼吸道病原微生物检测引物组合、试剂盒及其应用 | |
CN112831604B (zh) | 基于靶向测序的病原微生物检测引物组、试剂盒及方法 | |
US20180135108A1 (en) | Method for detecting bacterial and fungal pathogens | |
CN111269995B (zh) | 用于检测病原体的引物组、试剂盒和检测方法 | |
US20020086289A1 (en) | Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms | |
WO2023087868A1 (en) | Compositions, kits, methods for detecting and identifying pathogens that cause respiratory tract infections and use thereof | |
CN110964840A (zh) | 用于检测5种血流感染病原体的引物组、试剂盒及建库方法 | |
US20220411852A1 (en) | Composition for detecting pathogens, and kit and method therefor | |
CN113025761A (zh) | 病原微生物鉴定的多重扩增配合高通量测序方法及试剂盒 | |
CN112458212A (zh) | 同时检测甲型流感病毒、乙型流感病毒及呼吸道合胞病毒的试剂盒 | |
CN113046452B (zh) | 一种用于检测类鼻疽伯克霍尔德菌的组合物及其应用 | |
CN114317786A (zh) | 检测14种呼吸道感染病原菌的引物探针组合、试剂盒及其应用 | |
CN111411144B (zh) | 一种用于血流感染病原诊断的血浆游离dna标志物 | |
CN113265452A (zh) | 一种基于Nanopore宏基因组RNA-seq的生物信息学检测病原体的方法 | |
CN110423835B (zh) | 用于下呼吸道病原微生物检测的引物组合物 | |
CN116144811B (zh) | 用于检测脑脊液病原的多重引物组、方法和试剂盒 | |
CN116287357A (zh) | 一种基于靶向扩增子测序的呼吸道病原菌检测试剂盒 | |
CN109628621B (zh) | 一种检测肺炎克雷伯氏菌的实时定量lamp引物组及试剂盒 | |
CN117025808A (zh) | 一种病原微生物检测引物组合、试剂盒和检测方法 | |
CN114196767B (zh) | 特异性分子靶标及其检测金黄色葡萄球菌st型的方法 | |
CN116287479B (zh) | 一种检测呼吸道病毒的引物组合及其应用 | |
WO2024018485A1 (en) | Methods and systems for detection and identification of pathogens and antibiotic resistance genes | |
CN116949212A (zh) | 一种检测传染性疾病病原体的引物组、试剂盒及其应用 | |
CN114807334A (zh) | 目标基因的检测方法、引物组、试剂盒及应用 | |
CN106929605B (zh) | 一种能同时检测和鉴别口蹄疫和水泡性口炎的检测试剂盒及引物和探针 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Pengming Inventor after: Yang Rentao Inventor after: Gong Hao Inventor after: Wang Dongsheng Inventor after: Zhan Taiping Inventor after: Jiang Hua Inventor before: Chen Pengming Inventor before: Yang Rentao Inventor before: Gong Hao Inventor before: Wang Dongsheng Inventor before: Zhan Taiping Inventor before: Jiang Hua |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Unit 402-2, 4th Floor, Building 7 (3), Spiral Fourth Road, International Biological Island, Huangpu District, Guangzhou City, Guangdong Province, 510700 Patentee after: Guangzhou Jingwei Medical Technology Co.,Ltd. Country or region after: China Address before: Unit 402, 4th floor, building 3, No.7, helix 4 road, International Biological Island, Guangzhou, Guangdong 510300 Patentee before: Meige Medical Laboratory (Guangzhou) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |